Disclosure of Conflicts of Interest:
It is the policy of the Annenberg Center for Health Sciences at Eisenhower to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals with the potential to impact the content of an accredited education activity are expected to identify and reference off-label product use and disclose relevant financial relationships with ACCME-defined ineligible companies.
The Annenberg Center for Health Sciences assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant financial relationships that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
The faculty reported the following relevant financial relationships and/or other relationships they have with ineligible companies related to the content of this activity:
PhD, RN, MSN, APRN-BC, AOCN®, FAAN
|Beth Faiman has disclosed that she received consulting fees from Sanofi, Janssen, BMS, and Karyopharm.|
|Donna D. Catamero
ANP-BC, OCN, CCRC
|Donna D. Catamero has disclosed that she received speaking honoraria from GlaxoSmithKline and Oncopeptides, and advisory fees from Legend Biotech, Bristol Myers Squibb, and GlaxoSmithKline.|
DNP, RN, ANP-BC, AOCN®
|Kim Noonan has no relevant financial relationships to report.|
PhD, ANP-BC, AOCNP®
|Tiffany Richards has disclosed that she received consulting fees from BMS, GSK, Sanofi, and Janssen.|
The staff reported the following relevant financial relationships they have with ineligible companies related to the content of this activity:
RN, MA, EdM
|Diane Moran has no relevant financial relationships to report.|
|Michelle Faber has no relevant financial relationships to report.|
|Joyce Divine has no relevant financial relationships to report.|
|Maya Ormsby has no relevant financial relationships to report.|
All of the relevant financial relationships listed for these individuals have been mitigated.